HiSiaddi is an innovative foreign trade service provider driven by technology transformation and export business. We have established a service system of "1+2+3+4=1" and can supply genuine NPGDA from multiple well-known original manufacturers. With over a decade of market experience and deep collaboration with factories on technology conversion, HiSiaddi possesses extensive expertise in product compliance issues. Below is a case where HiSiaddi resolved full-chain compliance challenges for NPGDA exports.
Contact HiSiaddi customer service for further inquiries on NPGDA product compliance matters.
The buyer, MEDIBOND, a medical new materials firm headquartered in Lyon, France, is a designated EU Class II medical device raw material supplier specializing in UV bonding adhesives for medical catheters, light-transmissive coatings for minimally invasive instruments, and dental photosensitive resins. Its products hold EU CE medical device certification and ISO13485 medical quality management system accreditation, with all raw materials fully complying with EU REACH Regulation, RoHS2.0 Directive, and EU food contact framework regulations. MEDIBOND regularly imports high-purity neopentyl glycol diacrylate (NPGDA, CAS: 2223-82-7, UN2810, Class 6.1 toxic dangerous goods) from Arkema with an annual procurement volume of 220 tons. Amid rising prices of local European chemical raw materials and extended lead times from overseas major manufacturers, the client finalized sourcing from a leading domestic monomer factory with an initial trial order of 22 tons of mid-to-high-end optical medical-grade NPGDA, scheduled for full-container sea shipment from Shanghai Port to Le Havre Port, France.
Upon completion of raw material stocking and prior to container loading, four critical compliance non-conformities emerged, prompting MEDIBOND’s legal and procurement teams to immediately suspend shipment. The full container was detained at Shanghai’s dedicated dangerous goods warehouse. Failure to complete full-dimensional compliance rectification within 7 working days would force return of the entire container to China, generating over 120,000 EUR in direct costs including ocean freight, storage surcharges, and return container fees. Meanwhile, the client’s medical production line faced shutdown risks and order breach compensation liabilities due to raw material shortages. The four core compliance roadblocks were as follows:
1. SDS (Safety Data Sheet) supplied by the original manufacturer failed to meet the latest EU REACH Annex II standard EU2020/878, rendering documentation unrecognizable by French customs;
2. Missing REACH SVHC Substance of Very High Concern screening reports and Annex XVII restricted substance compliance certificates, preventing the EU importer from completing registration in the official system;
3. Non-compliant dangerous goods packaging and outer carton GHS hazard labels violating the IMDG International Maritime Dangerous Goods Code, leading shipping lines to reject booking requests;
4. Discrepancies between domestic outgoing dangerous goods declaration documentation, Chinese public labels, and EU import clearance document parameters, blocking export commodity inspection approval.
The domestic production factory only held domestic production qualifications and national standard quality certificates, capable solely of issuing factory COA reports. Lacking capacity to develop EU-compliant documentation, the factory had no understanding of REACH regulatory details or additional control clauses for EU medical raw materials and could not independently revise full compliance documentation. Recommended by the European Fine Chemicals Federation, MEDIBOND fully entrusted HiSiaddi – equipped with dedicated compliance engineers, cooperative CNAS-certified laboratories, and deep expertise in UV monomer import/export compliance – to fully resolve full-process compliance challenges within a 6-day deadline for on-time shipment.
The original MSDS provided by the raw material factory was compiled per outdated Chinese national standards, with 16-chapter structure, hazard classification, toxicology data, and waste disposal protocols following obsolete specifications. It failed to update content in accordance with REACH Annex II (EU2020/878), lacking mandatory required elements including SVHC substance declarations, disclosure of trace byproduct components, EU local emergency response provisions, and occupational exposure limits. Only a Chinese-language version was provided, without French-English bilingual SDS mandatory for French customs clearance. Per current EU regulations, customs authorities retain the right to detain goods, impose fines, and enforce mandatory return shipments for imported chemicals lacking compliant updated SDS documentation.
The client’s products serve EU Class II medical device coatings, subject to additional RoHS2.0 electronic medical directive controls alongside standard REACH requirements. The original supplier failed to conduct third-party authoritative testing: ① No full screening of over 230 candidate SVHC Substances of Very High Concern under REACH, precluding issuance of non-excess declarations; ② Absence of testing for 10 heavy metals and 4 phthalate restricted substances controlled by RoHS; ③ Missing test certificates for Annex XVII restricted hazardous substances (polycyclic aromatic hydrocarbons, halogenated hydrocarbons). The French importer cannot complete annual raw material registration in the ECHA European Chemicals Agency system without these documents, barring goods entry into the EU. Most ordinary domestic manufacturers only control primary product content and rarely provide specialized environmental testing for high-end medical raw materials.
NPGDA is classified as UN2810, Class 6.1 toxic organic liquid, Packing Group III, a legally defined maritime dangerous good. The original cargo utilized standard closed iron drums without UN dangerous goods packaging certification; outer cartons lacked compliant French GHS hazard labels, UN numbers, and emergency contact information. Drum bodies were not equipped with leak-proof inner plugs, failing IMDG maritime dangerous goods packaging strength requirements, leading shipping agents to reject container booking after document verification.
Three parameter discrepancies existed between trace impurity indicators, MEHQ polymerization inhibitor content, and product components marked on the factory’s domestic dangerous goods public labels and English documentation submitted to French customs. Disagreements between domestic export commodity inspection filing declaration elements, HiSiaddi HS code subdivision classification interpretations, and EU import declaration code definitions blocked customs clearance approval during outgoing inspection.
HiSiaddi immediately formed a four-person special project team consisting of compliance officers, third-party testing coordinators, dangerous goods packaging rectification specialists, and customs declaration officers. The 6-day timeline was split into parallel workstreams for document revision, third-party testing, packaging replacement, and customs declaration documentation adjustment to fully resolve all compliance roadblocks.
1. HiSiaddi compliance engineers extracted full-component test data (primary monomer, residual acrylic acid, neopentyl glycol, MEHQ polymerization inhibitor, trace byproducts, metal impurities) to fully recompile the 16-chapter compliant SDS in strict alignment with REACH Annex II EU2020/878 latest regulation. Mandatory required content including SVHC substance disclaimers, EU waste disposal regulations, local French emergency institution contact details, and workshop exposure limit values were supplemented;
2. Concurrent development of formal English-French bilingual SDS versions, affixed with HiSiaddi foreign trade compliance official seals and the original manufacturer’s production stamp, with electronic copies for pre-declaration to French customs and physical hard copies accompanying the full container shipment;
3. Separate issuance of a REACH compliance statement certifying full pre-registration of all product components under EU REACH, listing ECHA pre-registration numbers to satisfy mandatory EU importer filing requirements.
1. HiSiaddi coordinated nearby third-party testing laboratories with mutually recognized EU report qualifications to extract representative samples of the NPGDA batch for expedited completion of two core testing categories: ① Full REACH-SVHC screening (232 high-concern substances): All component SVHC levels ＜0.01%, far below the EU 0.1% notification threshold. A bilingual Chinese-English CNAS authoritative test report and non-excess SVHC compliance statement were issued; ② RoHS2.0 + REACH Annex XVII restricted substance testing: Controlled components including lead, cadmium, mercury, hexavalent chromium, four phthalates, polybrominated compounds, and polycyclic aromatic hydrocarbons all fell below EU statutory limits. A medical device-specific Declaration of Conformity (DoC) compliance document was issued to support CE certification audits for the client’s finished medical products.
2. Hard copies of test reports were sent to the client’s legal department in France for filing, with electronic versions uploaded in advance to the French customs pre-inspection system.
1. HiSiaddi coordinated a Shanghai compliant dangerous goods packaging factory to remove non-compliant standard iron drums, fully replacing all 22 tons of NPGDA with UN-certified 200L steel drums equipped with leak-proof internal coatings and anti-leakage liners. Each steel drum was accompanied by UN packaging performance certificates and use appraisal documents, meeting IMDG maritime Class 6.1 dangerous goods packaging specifications;
2. Custom French-English bilingual hazard labels were printed in accordance with the EU GHS Globally Harmonized System, marking UN2810, hazard Class 6.1, protective warnings, emergency contact numbers, product CAS number, commodity name, manufacturer, and EU importer information. Uniform labeling across all drums enabled secondary verification by the shipping company to release container booking space.
1. HiSiaddi accurately identified the HS code corresponding to NPGDA aligned with EU customs code definitions, unifying declaration elements, product physicochemical indicators, and impurity data for both domestic export customs clearance and French import customs clearance, correcting the original three data conflict points;
2. Recreated Chinese drum labels compliant with domestic Chinese dangerous goods public disclosure standards, fully aligning domestic dangerous goods declaration and outgoing commodity inspection documentation parameters with overseas customs documents, submitting materials to Shanghai Customs for dangerous goods export inspection and successfully obtaining outgoing clearance permits.
1.
On-Time Container Loading & Dispute-Free Customs Clearance in France All compliance documentation, packaging rectification, and test reports were finalized by the 5th working day, enabling full-container loading and scheduled sea departure from Shanghai Port to Le Havre Port, France. Upon cargo arrival, French customs verified complete bilingual SDS, SVHC test reports, RoHS compliance declarations, and UN dangerous goods packaging documentation, completing one-time dispute-free clearance and delivery of raw materials to the client’s production plant in Lyon without production shutdown or breach losses.
2.
3.
Long-Term Annual Contract Signed with Full-Category Raw Material Compliance Entrustment Following successful resolution of the compliance crisis, French MEDIBOND fully recognized HiSiaddi’s full-chain compliance service capacity and immediately finalized a long-term domestic procurement contract for 215 tons of NPGDA per year. Subsequent domestic sourcing, compliance audits, and export customs clearance services for multiple medical UV monomers including HDDA and TPGDA were fully entrusted to HiSiaddi for full lifecycle management. HiSiaddi established exclusive compliance archives for the client, conducting pre-REACH and RoHS compliance audits for every batch prior to shipment to eliminate compliance risks at the source.
4.
5.
Expansion of Supporting Value-Added Compliance Services Drawing on extensive experience with EU medical raw material compliance, HiSiaddi assisted the client in coordinating domestic manufacturers to optimize internal product control indicators, establishing factory batch testing protocols for medical-grade NPGDA to attach full compliance documentation with every outgoing batch. We also track annual updates to the EU REACH SVHC candidate list, regularly updating SDS versions and compliance statements yearly to resolve long-term compliance control pain points for overseas mid-to-high-end clients.
6.
1. Compliance Capacity Gap Between Domestic Manufacturers and Overseas End Clients Is a Common Export Pain Point: Most domestic NPGDA manufacturers focus solely on national standard production and product purity indicators, catering to standard domestic coating and ink markets without familiarity with cross-border regulations including EU REACH, RoHS, GHS labeling, and IMDG maritime dangerous goods codes. While products satisfy domestic sales requirements, they fail to meet stringent compliance standards for EU medical and optoelectronic mid-to-high-end clients. Factories lack rectification capacity when sudden compliance issues arise for overseas orders, risking costly container detention and forced return shipments;
2. Distinct Compliance Logic Between EU Mid-to-High-End Medical End Manufacturers and Low-End Traders: Low-end purchasers prioritize unit price, spot inventory, and delivery lead times, while EU medical-grade clients are bound by EU medical device regulations requiring five non-negotiable compliance pillars: SDS compliance, SVHC screening, RoHS environmental testing, dangerous goods packaging, and customs declaration. Compliance documentation is required not only for customs clearance but also to be retained in client finished product CE certification archives for 10 years. Goods cannot be warehoused or put into production even with compliant physicochemical indicators if documentation fails regulatory requirements;
3. HiSiaddi’s Differentiated Core Competitive Edge: Integrated trade + compliance services. Moving beyond the traditional intermediary model limited to raw material sourcing matching, we deploy a dedicated compliance engineering team and third-party testing resources to pre-empt export compliance risks through pre-order compliance audits. In the event of sudden compliance failures, we deliver rapid full-chain rectification, filling compliance gaps for domestic manufacturers while helping overseas mid-to-high-end clients avoid EU regulatory penalties and detention losses – the core driver securing long-term repeat orders from premium overseas end customers.
Contact HiSiaddi customer service for further inquiries on NPGDA product compliance matters.
+86-13120989737 
info@hisiaddi.com 
English
